Elizabeth Ingulli is a Nephrology physician affiliated with University of San Diego. OpenAlex indexes 112 publications with 5,989 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8001 Frost St
Entrance 10
San Diego, CA 921232746
Telephone
858-966-8052Registry record last updated 14 Oct 2011.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20251 payment
- One Lambda, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.4%Calcium channel blocker42.9%Amlodipine Besylate100%Part D<11 patientsBeta blocker26.5%Atenolol100%Part D<11 patientsMetabolism & gastrointestinal
30.6%Vitamin D3 Analog30.6%Calcitriol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2006–2007 per NIH RePORTER. The latest:
- Self-ligand Deprivation as a Strategy to Induce Tolerance
University of California, San Diego
FY2007$200,754R21AI069836 - Self-ligand Deprivation as a Strategy to Induce Tolerance
University of California, San Diego
FY2006$117,962R21AI069836
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cost Efficacy of Rapid Whole Genome Sequencing in the Pediatric Intensive Care Unit
Frontiers in Pediatrics
2022 - Organ transplantation using COVID-19-positive deceased donors
American Journal of Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Victor Nizet, MD
University of San Diego
Christopher Kane, MD
University of San Diego
Lawrence Marshall, MD
University of San Diego
Lyudmila Bazhenova, MD
University of San Diego
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”